Boise Pharmacotherapy Resident Forum 2009-2010
The Boise Pharmacotherapy Resident Forum is designed to assist and faciliate Pharmacy residents (PGY1 and PGY2) in the Boise area to gather and formally present clinically relevant topics.  The goal of Pharmacotherapy Rounds is to enhance the participants's knowledge regarding the use of drug therapy to treat and prevent disease.  Participants will learn to evaluate the scientific literature and discuss its applicability to clinical practice.  Participants will learn to present the complex concepts and scientific data in a clear and concise manner.

Clinicial Pharmacy Residents will be expected to utlize and apply the knowledge from such diverse areas as pharmacology, therapeutics, drug information, pharmacokinetics, pharmacoeconomics, and clinical practice.  Additionally, writing and presentation skills will be emphasized.  These skills will be obtained through the following formats:


Pharmacotherapy Rounds will be held Wednesday afternoons from 3:00 - 5:00 PM and the location will vary (Saint Alphonsus, St. Luke's, Boise VA Medical Center, and Ladd Family Pharmacy) depending on the presenter's practicing facility and coordinator schedule.  The audience will consist of phamacy residents, pharmacy practitioners, pharmacy students, and invited guests.

Reference Materials

2009-2010 Syllabus

2009-2010 Schedule - updated 02-08-10

Residency Presentation Evaluation

Sept. 9 Journal Club (Griffiths): Renal and retinal effects of enalapril and losartan in Type1DM

Sept. 16 Journal Club (Mancini): DES Vs Bare Metal Stents

Sept 16 Journal Club (Kaster): Rivaroxaban_in_Total_knees

Sept. 30 Journal Club: (Dane Kaster) VYCTOR Study

Oct. 14 Journal Club (Oswald): Aztreonam Lysine for Pseudomonas in CF

Oct. 14 Journal Club (Ingram): Efficacy and Tolerability of Tapentadol

Oct. 28 Journal Club (Halse): Second course of IBU in closure of PDA

Oct. 28 Journal Club (Mohlman): Ticagrelor vs Clopidogrel in ACS

Nov. 4 Journal Club (Otting): Dabigatran vs warfarin in patients with A Fib

Nov. 18 Journal Club (List): A trial of Darbepoetin alfa in Type 2 DM and CKD

Nov. 18 Journal Club (Crane): Efficacy and Safety of Saxagliptin when added to Metformin